Product Information

PIOGLITAZONE-METFORMIN 15-850 is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2932 per EA under NDC 33342017709. Its NADAC has been published 472 times since Jun 14, 2017.

PIOGLITAZONE-METFORMIN 15-850

Pioglitazone and metformin hydrochloride
$0.2932per EA

Strength

850; 15 mg/1; mg/1

NDC

33342017709

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA204802

On Market Since

11/6/2015

Pharmacological Classes

Biguanide
Biguanides
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE-METFORMIN 15-850 has been published 472 times since Jun 14, 2017, and over the history we have for it it has declined 78.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2932 per EA
All-time high$1.3399 (Jun 14, 2017)
All-time low$0.2180 (May 22, 2024)
52-week high$0.2990
52-week low$0.2441
Median price$0.5097
Average price$0.5559
Largest weekly change-54.8% (Sep 20, 2023)
Weeks tracked472
Tracking sinceJun 14, 2017

Price History

1W

0.0%

1M

+4.2%

3M

+4.1%

6M

-0.1%

1Y

+20.1%

3Y

-21.9%

5Y

-48.1%

All

-78.1%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE-METFORMIN 15-850?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE-METFORMIN 15-850, manufactured by Macleods Pharmaceuticals Limited, is $0.2932 per EA (NDC 33342017709), effective Jun 24, 2026.

How has the price of PIOGLITAZONE-METFORMIN 15-850 changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE-METFORMIN 15-850 has declined 78.1%. It has been tracked across 472 weekly CMS publications since Jun 14, 2017.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE-METFORMIN 15-850?

Since Jun 14, 2017, the NADAC for PIOGLITAZONE-METFORMIN 15-850 has ranged from a low of $0.2180 (May 22, 2024) to a high of $1.3399 (Jun 14, 2017), with a median of $0.5097 per EA.

Are there cheaper alternatives to PIOGLITAZONE-METFORMIN 15-850?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as PIOGLITAZONE-METFORMIN 15-850, but none are currently priced below it.

Who manufactures PIOGLITAZONE-METFORMIN 15-850?

PIOGLITAZONE-METFORMIN 15-850 (NDC 33342017709) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.